(Q44407577)

2 December 2017

Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma (English)

1 reference

2 December 2017

Masatoshi Tanaka

1

1 reference

2 December 2017

Eiji Ando

2

1 reference

2 December 2017

Shigeo Simose

3

1 reference

2 December 2017

Maisa Hori

4

1 reference

2 December 2017

Kei Kuraoka

5

1 reference

2 December 2017

Miki Ohno

6

1 reference

2 December 2017

Shigeru Yutani

7

1 reference

2 December 2017

Kazunori Harada

8

1 reference

2 December 2017

Michio Sata

9

1 reference

2 December 2017

24 March 2013

1 reference

2 December 2017

1 reference

2 December 2017

44

1 reference

2 December 2017

2

1 reference

2 December 2017

194-200

1 reference

Estimating the world cancer burden: Globocan 2000.

2 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Image-guided tumor ablation: standardization of terminology and reporting criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Chemoembolization for intermediate HCC: is there proof of survival benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12100

21 January 2018

Identifiers

DOI

10.1111/HEPR.12100

1 reference

2 December 2017

1 reference